Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Kitzis

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Pathologie-Biologie|May 1, 1979
[Modified method for assay of cephalosporins and cephamycins (author's transl)]M D Kitzis
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 18, 2003
Vancomycin-resistant Staphylococcus aureus: no apocalypse nowF W Goldstein, M D Kitzis
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 8, 2006
Monitoring of vancomycin serum levels for the treatment of staphylococcal infectionsM D Kitzis, F W Goldstein
Antimicrobial Agents and Chemotherapy|January 1, 1996
In vitro selection of one-step mutants of Streptococcus pneumoniae resistant to different oral beta-lactam antibiotics is associated with alterations of PBP2xF Sifaoui, M D Kitzis, L Gutmann
The Journal of Antimicrobial Chemotherapy|November 1, 1990
The in-vitro activity of cefodizime: a reviewC J Soussy, M Chanal, M D Kitzis
The Journal of Antimicrobial Chemotherapy|June 1, 1984
Recovery period after exposure of Staphylococcus aureus to sub-inhibitory and bactericidal concentrations of rifampicin: clinical implicationsM D Kitzis, L Gutmann, J F Acar
Pathologie-Biologie|June 1, 1994
[Antibacterial activity of ciprofloxacin in the urine during four days after a single 500 mg and 750 mg oral dose]J Guibert, M D Kitzis, J F Acar
La Nouvelle Presse Medicale|February 26, 1981
[Kinetics of cefotaxime in healthy subjects (author's transl)]J F Acar, J Guibert, M D Kitzis
APMIS. Supplementum|January 1, 1989
The incidence of beta-lactamase-producing pathogensJ F Acar, M D Kitzis, L Gutmann
The Journal of Antimicrobial Chemotherapy|January 1, 1985
In-vitro susceptibility of Nocardia asteroides to 21 beta-lactam antibiotics, in combination with three beta-lactamase inhibitors, and its relationship to the beta-lactamase contentM D Kitzis, L Gutmann, J F Acar
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Pathologie-Biologie|May 1, 1979
[Modified method for assay of cephalosporins and cephamycins (author's transl)]M D Kitzis
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 18, 2003
Vancomycin-resistant Staphylococcus aureus: no apocalypse nowF W Goldstein, M D Kitzis
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 8, 2006
Monitoring of vancomycin serum levels for the treatment of staphylococcal infectionsM D Kitzis, F W Goldstein
Antimicrobial Agents and Chemotherapy|January 1, 1996
In vitro selection of one-step mutants of Streptococcus pneumoniae resistant to different oral beta-lactam antibiotics is associated with alterations of PBP2xF Sifaoui, M D Kitzis, L Gutmann
The Journal of Antimicrobial Chemotherapy|November 1, 1990
The in-vitro activity of cefodizime: a reviewC J Soussy, M Chanal, M D Kitzis
The Journal of Antimicrobial Chemotherapy|June 1, 1984
Recovery period after exposure of Staphylococcus aureus to sub-inhibitory and bactericidal concentrations of rifampicin: clinical implicationsM D Kitzis, L Gutmann, J F Acar
Pathologie-Biologie|June 1, 1994
[Antibacterial activity of ciprofloxacin in the urine during four days after a single 500 mg and 750 mg oral dose]J Guibert, M D Kitzis, J F Acar
La Nouvelle Presse Medicale|February 26, 1981
[Kinetics of cefotaxime in healthy subjects (author's transl)]J F Acar, J Guibert, M D Kitzis
APMIS. Supplementum|January 1, 1989
The incidence of beta-lactamase-producing pathogensJ F Acar, M D Kitzis, L Gutmann
The Journal of Antimicrobial Chemotherapy|January 1, 1985
In-vitro susceptibility of Nocardia asteroides to 21 beta-lactam antibiotics, in combination with three beta-lactamase inhibitors, and its relationship to the beta-lactamase contentM D Kitzis, L Gutmann, J F Acar
Pageof 9